Linezolid and vancomycin in treatment of lower-extremity complicated skin and skin structure infections caused by methicillin-resistant staphylococcus aureus in patients with and without vascular disease
Surgical Infections, 06/12/2012
Duane TM et al. – Linezolid is an effective treatment for patients with and without vascular disease who have a lower–extremity cSSSI caused by MRSA. The safety data were consistent with the known safety profiles of linezolid and vancomycin given for this indication.